Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hip surgery pain relief: less may be more?

NCT ID NCT07023120

Symptom relief Sponsor: Poznan University of Medical Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how much numbing medicine (ropivacaine) and whether adding dexamethasone affects pain control after hip replacement. 120 adults were split into four groups, each getting a different combination. The goal was to see which approach delays the need for strong painkillers and reduces overall opioid use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ropivacaine and dexamethasone
What this could lead to
If successful, this could lead to better pain relief and less opioid use after hip replacement surgery.
What could go wrong
This is a small, completed Phase 4 trial. The results may not apply to all patients or surgeries, and the best dose may still need more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

120 people

The number who actually took part.

Started

Jun 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 years scheduled for primary unilateral total hip arthroplasty (THA). * American Society of Anesthesiologists (ASA) physical status I-III. * Ability to provide written informed consent. * Spinal anesthesia planned as the primary anesthetic technique. * Body mass index (BMI) between 18 and 35 kg/m². * Fluent in the local language and able to understand the NRS pain scoring system. Exclusion Criteria: * Known allergy or hypersensitivity to ropivacaine, dexamethasone, or other amide local anesthetics. * Pre-existing neurological deficits or neuropathies affecting lower limb motor or sensory function. * Chronic opioid use (daily use \>30 mg oral morphine equivalents for \>1 month prior to surgery). * History of coagulopathy, current anticoagulant therapy not eligible for regional anesthesia. * Uncontrolled diabetes mellitus (HbA1c \> 9%) or active systemic infection. * Pregnancy or breastfeeding. * Previous surgery or implantation on the ipsilateral hip. * Inability to cooperate with postoperative assessments or participate in follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip arthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip arthritis Hip arthropathy Hip osteoarthritis

Contacts and locations

Locations

  • Poznan University of Medical Sciences

    Poznan, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.